Reference answer · 340b-program · reviewed quarterly
Last updated
Review cadence: quarterlyUnderlying federal data: refreshed weekly to annual per source
Q&A library · 340b-program

How does HRSA determine 340B drug diversion during covered entity audits?

HRSA identifies 340B drug diversion by tracing each claim’s documentation from patient encounter to prescription to dispense. Auditors verify that the prescriber is linked to the covered entity and that all records—encounter notes, prescribing data, and dispensing logs—connect seamlessly. Missing or disconnected data usually results in a diversion finding.